Taiwanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Caliway Biopharmaceuticals

Market Cap: NT$168.1b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Formosa Laboratories

Market Cap: NT$6.2b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.8b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Bonraybio

Market Cap: NT$3.8b

A development stage company, manufactures medical instruments and solutions for the male infertility market.

Maxigen Biotech

Market Cap: NT$3.4b

Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.

HeXun Biosciences

Market Cap: NT$2.8b

Engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.8b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

Synbio Tech

Market Cap: NT$1.7b

Manufactures and sells human healthcare products and probiotics for animals.

Winston Medical Supply

Market Cap: NT$1.1b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Prince Pharmaceutical

Market Cap: NT$1.1b

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.